chartexchange

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study

GlobeNewswire Inc. | Nov 18, 2026 3:00 AM EST

Entrada Therapeutics announces that an independent DMC recommends initiation of Cohort 3 at the dose of 15 mg/kg in the ELEVATE-45-201 study.

Read original article